IRIS
MAFFEZZOLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.064
NA - Nord America 892
EU - Europa 432
SA - Sud America 176
AF - Africa 70
OC - Oceania 4
Totale 2.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 865
SG - Singapore 404
VN - Vietnam 223
CN - Cina 193
IT - Italia 151
BR - Brasile 142
HK - Hong Kong 85
FR - Francia 58
DE - Germania 47
ZA - Sudafrica 42
NL - Olanda 37
GB - Regno Unito 34
IN - India 32
IE - Irlanda 24
BD - Bangladesh 22
RU - Federazione Russa 19
AR - Argentina 17
IQ - Iraq 14
KR - Corea 14
CA - Canada 12
JP - Giappone 12
AT - Austria 11
SE - Svezia 11
MA - Marocco 10
MX - Messico 9
FI - Finlandia 8
PH - Filippine 8
TR - Turchia 8
UZ - Uzbekistan 8
ES - Italia 7
MY - Malesia 7
TH - Thailandia 7
CO - Colombia 6
ID - Indonesia 6
PK - Pakistan 6
PL - Polonia 6
EC - Ecuador 5
EG - Egitto 5
KE - Kenya 5
AU - Australia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CI - Costa d'Avorio 3
LT - Lituania 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
JM - Giamaica 2
PE - Perù 2
SA - Arabia Saudita 2
UA - Ucraina 2
BB - Barbados 1
BN - Brunei Darussalam 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 2.638
Salva come PNG Salva come JPEG
Città #
Singapore 262
Dallas 169
Ashburn 168
San Jose 118
Hong Kong 82
Santa Clara 75
Ho Chi Minh City 69
Beijing 46
Boardman 45
Hanoi 42
Johannesburg 39
Hefei 35
Munich 25
Dublin 24
Lauterbourg 22
Los Angeles 22
Milan 22
Parma 18
Marseille 16
São Paulo 14
Buffalo 13
Modena 13
Shanghai 13
Da Nang 12
New York 12
Seoul 11
Brooklyn 9
Chennai 9
Haiphong 9
Moscow 9
Orem 9
Paris 9
Tokyo 9
Bengaluru 8
Atlanta 7
Bologna 7
Council Bluffs 7
Denver 7
London 7
Nuremberg 7
Portsmouth 7
Rio de Janeiro 7
Tashkent 7
Amsterdam 6
Columbus 6
Frankfurt am Main 6
Houston 6
Meknes 6
Montreal 6
Poplar 6
Turku 6
Vienna 6
Baghdad 5
Bangkok 5
Chicago 5
Quito 5
Stockholm 5
Curitiba 4
Nairobi 4
Ninh Bình 4
Sungai Petani 4
Warsaw 4
Aachen 3
Abidjan 3
Bauru 3
Belo Horizonte 3
Biên Hòa 3
Boston 3
Brescia 3
Buenos Aires 3
Cape Town 3
Düsseldorf 3
Genoa 3
Lahore 3
Paderno Dugnano 3
Phoenix 3
Poços de Caldas 3
Salt Lake City 3
Scandiano 3
Thái Nguyên 3
Tianjin 3
Ancona 2
Baku 2
Brasília 2
Brussels 2
Busto Arsizio 2
Bắc Ninh 2
Cairo 2
Can Tho 2
Caxias do Sul 2
Chandigarh 2
Dhaka 2
Dubai 2
Erbil 2
Felino 2
Foshan 2
Goiânia 2
Ha Long 2
Honolulu 2
Hải Dương 2
Totale 1.715
Salva come PNG Salva come JPEG
Nome #
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?—a narrative review 174
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 147
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 145
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 121
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 115
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 114
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 113
External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK. 112
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 111
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 110
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 109
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations 107
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 102
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 92
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 90
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 88
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 84
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 82
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 80
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study 77
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. 77
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review 76
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 73
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental Survey 69
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 66
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon? 55
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review 41
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort 37
Totale 2.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/2024121 0 8 4 3 14 13 13 9 16 9 15 17
2024/2025648 7 36 44 35 69 69 38 49 55 57 59 130
2025/20261.837 154 156 328 199 249 136 160 91 242 122 0 0
Totale 2.667